• Main
  • About company
    • About company
    • PJSC "Technolog"
    • PJSC “Lekhim-Kharkiv”
    • Lekhim-Obukhiv LLC
    • UAB «LEKHIM-VILNIUS»
    • FP «LEKHIM» LLC
    • Safety and pharmacovigilance (Technolog)
    • Safety and pharmacovigilance (Kharkiv)
    • Partners
  • Production
    • Medicinal products
    • Veterinary products
    • Natural drinking water Enjoy
    • Natural drinking water Cenoman
  • PHARMACIES
  • Export
  • News
  • Contacts
Products
Menu
  • Medicinal products
  • Veterinary products
  • Natural drinking water Enjoy
  • Natural drinking water Cenoman
/
  • Alphabetically
  • By group of action
  • By active ingredient
Home / Products / Group actions
A.
47
Agents affecting the digestive system and metabolism
A.

Agents affecting the digestive system and metabolism

Name Dosage form ATC code
Alpha-tocopherol acetate (vitamin E)
 
Alpha-tocopherol acetate (vitamin E)
50 mg/ml, 20 ml № 1
Oral oil solution
Active ingredient
Vitamin E-acetate
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
50 mg/ml, 20 ml № 1 A11HA03
Alpha-tocopherol acetate (vitamin E)
 
Alpha-tocopherol acetate (vitamin E)
100 mg/ml, 20 ml № 1
Oral oil solution
Active ingredient
Vitamin E-acetate
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
100 mg/ml, 20 ml № 1 A11HA03
Alpha-tocopherol acetate (vitamin E)
 
Alpha-tocopherol acetate (vitamin E)
300 mg/ml, 20 ml № 1
Oral oil solution
Active ingredient
Vitamin E-acetate
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
300 mg/ml, 20 ml № 1 A11HA03
Aquavit-D3
 
Aquavit-D3
375 mcg/ml, 10 ml № 1
Oral solution
Active ingredient
Colecalciferol
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
375 mcg/ml, 10 ml № 1 A11CC05
Ascorbic acid
 
Ascorbic acid
50 mg/ml, 2 ml № 10, № 100
Solution for injections
Active ingredient
Ascorbic acid
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
50 mg/ml, 2 ml № 10, № 100 A11GA01
Ascorbic acid
 
Ascorbic acid
100 mg/ml, 2 ml № 10, № 100
Solution for injections
Active ingredient
Ascorbic acid
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
100 mg/ml, 2 ml № 10, № 100 A11GA01
Ascorbic acid
 
Ascorbic acid
25 mg №50
Tablets
Active ingredient
Ascorbic acid
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
25 mg №50 A11GA01
Ascorbic acid
 
Ascorbic acid
25 mg № 100
Tablets
Active ingredient
Ascorbic acid
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
25 mg № 100 A11GA01
Ascorbic acid
 
Ascorbic acid
50 mg № 50
Dragee
Active ingredient
Ascorbic acid
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
50 mg № 50 A11GA01
Bisacodyl
 
Bisacodyl
0,01 g № 10
Rectal suppositories
Active ingredient
Bisacodyl
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
0,01 g № 10 A06AB02
Carbacid Pechaevskiy
 
Carbacid Pechaevskiy
№ 20
Chewable tablets
Active ingredient
Comb drug
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
№ 20 A02AX
Contracid
 
Contracid
40 mg №1
Powder for solution for injections
Active ingredient
Pantoprazol
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
40 mg №1 А02В С02
Dalmaxin
 
Dalmaxin
0,2 g № 5, № 10
Suppositories
Active ingredient
Thiotriazolin
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
0,2 g № 5, № 10 A05BA
Diosmectite
 
Diosmectite
3,0 g №10
Powder for oral solution
Active ingredient
Diosmectite
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
3,0 g №10 A07BC05
Ergocalciferol (vitamin D2)
 
Ergocalciferol (vitamin D2)
0,125 %, 10 ml № 1
Oral oil solution
Active ingredient
Ergocalciferol
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
0,125 %, 10 ml № 1 A11CC01
Glibenclamide
 
Glibenclamide
5 mg № 30
Tablets
Active ingredient
Glibenclamide
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
5 mg № 30 А10ВВ01
Heksavit
 
Heksavit
№ 50
Dragee
Active ingredient
Comb drug
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
№ 50 A11BA
Kreazim 10000
 
Kreazim 10000
№ 20
Hard capsules
Active ingredient
Pancreatin
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
№ 20 A09AA02
Kreazim 20000
 
Kreazim 20000
№ 20
Hard capsules
Active ingredient
Pancreatin
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
№ 20 A09AA02
Lekplex
 
Lekplex
2 ml № 5
Active ingredient
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
2 ml № 5 А11DВ
Leksadyl
 
Leksadyl
10 mg № 10
Active ingredient
Bisacodyl
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
10 mg № 10 А06АВ02
Lektac
 
Lektac
150 mg № 10, № 20, № 30
Active ingredient
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
150 mg № 10, № 20, № 30 A02BA02
Loperamide
 
Loperamide
0,002 g № 10, № 20
Tablets
Active ingredient
Loperamide hydrochloride
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
0,002 g № 10, № 20 A07DA03
Methovitan
 
Methovitan
20 hard capsules
Hard capsules
Active ingredient
Comb drug
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
20 hard capsules А11АВ
Methyluracil
 
Methyluracil
0,5 g, № 5 ,№ 10
Rectal suppositories
Active ingredient
6-methyluracil
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
0,5 g, № 5 ,№ 10 A14B
Nevrolek
 
Nevrolek
2 ml № 5
Solution for injections
Active ingredient
Comb drug
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
2 ml № 5 A11DB
No-H-Sha
 
No-H-Sha
0,04 g № 10, № 30
Tablets
Active ingredient
Drotaverine hydrochloride
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
0,04 g № 10, № 30 A03A D02
No-H-Sha
 
No-H-Sha
20 mg/mg, 2 ml in ampoules № 5
Solution for injections
Active ingredient
Drotaverine hydrochloride
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
20 mg/mg, 2 ml in ampoules № 5 A03AD02
No-H-Sha
 
No-H-Sha
0,04 g № 10
Rectal suppositories
Active ingredient
Drotaverine hydrochloride
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
0,04 g № 10 A03AD02
No-H-Sha forte
 
No-H-Sha forte
0,08 g № 30
Tablets
Active ingredient
Drotaverine hydrochloride
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
0,08 g № 30 A03AD02
Ondansetron
 
Ondansetron
2 mg/ml 2 ml № 5
Solution for injections
Active ingredient
Ondansetron hydrochloride trihydrate
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
2 mg/ml 2 ml № 5 A04AA01
Ondansetron
 
Ondansetron
2 mg/ml 4 ml № 5
Solution for injections
Active ingredient
Ondansetron hydrochloride trihydrate
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
2 mg/ml 4 ml № 5 A04AA01
Ondansetron
 
Ondansetron
4 mg № 10
Film-coated tablets
Active ingredient
Ondansetron hydrochloride trihydrate
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
4 mg № 10 A04AA01
Ondansetron
 
Ondansetron
8 mg № 10
Film-coated tablets
Active ingredient
Ondansetron hydrochloride trihydrate
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
8 mg № 10 A04AA01
Pancreatin 8000
 
Pancreatin 8000
№ 20, №50
Enterosoluble tablets
Active ingredient
Pancreatin
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
№ 20, №50 A09AA02
Pancreazim
 
Pancreazim
№ 20, № 50
Enterosoluble tablets
Active ingredient
Pancreatin
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
№ 20, № 50 A09AA02
Pancreazim 10000
 
Pancreazim 10000
№ 20, № 50
Enterosoluble tablets
Active ingredient
Pancreatin
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
№ 20, № 50 А09АА02
Pancreazim 10000
 
Pancreazim 10000
№ 20, № 50
Active ingredient
Pancreatin
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
№ 20, № 50 А09АА02
Papaverine
 
Papaverine
20 mg/ml, 2 ml № 10
Solution for injections
Active ingredient
Papaverine hydrochloride
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
20 mg/ml, 2 ml № 10 A03AD01
Pyridoxine hydrochloride (vitamin В6)
 
Pyridoxine hydrochloride (vitamin В6)
50 mg/ml, 1 ml № 10
Solution for injections
Active ingredient
Pyridoxine hydrochloride
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
50 mg/ml, 1 ml № 10 A11HA02
Ranitidine
 
Ranitidine
150 mg №30
Film-coated tablets
Active ingredient
Ranitidine hydrochloride
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
150 mg №30 A02BA02
Ranitidine
 
Ranitidine
150 mg № 20
Film-coated tablets
Active ingredient
Ranitidine hydrochloride
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
150 mg № 20 A02BA02
Renalgan
 
Renalgan
5 ml №5
Solution for injections
Active ingredient
Metamizol natrii, fenpiverinium bromide, pitofenone hydrochloride
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
5 ml №5 A03DA02
Renalgan
 
Renalgan
№ 10
Tablets
Active ingredient
Metamizol natrii, fenpiverinium bromide, pitofenone hydrochloride
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
№ 10 A03DA02
Renalgan
 
Renalgan
2 ml №10
Solution for injections
Active ingredient
Metamizol natrii, fenpiverinium bromide, pitofenone hydrochloride
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
2 ml №10 A03DA02
Renalgan
 
Renalgan
№20
Tablets
Active ingredient
Metamizol natrii, fenpiverinium bromide, pitofenone hydrochloride
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
№20 A03DA02
Retinol acetate (vitamin A)
 
Retinol acetate (vitamin A)
34,4 mg/ml, 10 ml № 1
Oral oil solution
Active ingredient
Retinol acetate
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
34,4 mg/ml, 10 ml № 1 A11CA01
Revit
 
Revit
№ 75, № 100
Dragee
Active ingredient
Comb drug
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
№ 75, № 100 A11BA
Solizym forte
 
Solizym forte
№ 20
Enterosoluble tablets
Active ingredient
Microbiological lipase
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
№ 20 A09AA
Stomolik
 
Stomolik
125 ml № 1
Solution for oral cavity
Active ingredient
Hexetidine
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
125 ml № 1 А01АВ12
Thiamine chloride (vitamin В1)
 
Thiamine chloride (vitamin В1)
50 mg/ml, 1 ml in ampoules № 10
Solution for injections
Active ingredient
Thiamine hydrochloride
Pharmacotherapeutic group

Agents affecting the digestive system and metabolism

More
50 mg/ml, 1 ml in ampoules № 10 A11DA01
B.
10
Agents affecting blood system and hemapoiesis
B.

Agents affecting blood system and hemapoiesis

Name Dosage form ATC code
Aquaferrol
 
Aquaferrol
10 mg/ml, 125 ml № 1
Syrup
Active ingredient
Ferric oxide polymaltose complexes
Pharmacotherapeutic group

Agents affecting blood system and hemapoiesis

More
10 mg/ml, 125 ml № 1 В03АВ05
Cyanocobalamin (vitamin В12)
 
Cyanocobalamin (vitamin В12)
0,5 mg/ml, 1 ml № 10
Solution for injections
Active ingredient
Cyanocobalamin
Pharmacotherapeutic group

Agents affecting blood system and hemapoiesis

More
0,5 mg/ml, 1 ml № 10 B03BA01
Ferrofol
 
Ferrofol
№ 30
Chewable tablets
Active ingredient
Ferric oxide polymaltose complexes
Pharmacotherapeutic group

Agents affecting blood system and hemapoiesis

More
№ 30 В03АD04
Folic acid
 
Folic acid
5 mg № 50
Tablets
Active ingredient
Folic acid
Pharmacotherapeutic group

Agents affecting blood system and hemapoiesis

More
5 mg № 50 B03BB01
Folic acid
 
Folic acid
1 mg № 50
Tablets
Active ingredient
Folic acid
Pharmacotherapeutic group

Agents affecting blood system and hemapoiesis

More
1 mg № 50 B03BB01
Magnesium sulfate
 
Magnesium sulfate
250 mg/ml, 5 ml № 10
Solution for injections
Active ingredient
Magnesium sulfate heptahydrate
Pharmacotherapeutic group

Agents affecting blood system and hemapoiesis

More
250 mg/ml, 5 ml № 10 B05XA05
Sodium chloride
 
Sodium chloride
9 mg/ml, 5 ml №10
Solution for injections
Active ingredient
Sodium chloride
Pharmacotherapeutic group

Agents affecting blood system and hemapoiesis

More
9 mg/ml, 5 ml №10 B05XA03
Tranexamic acid
 
Tranexamic acid
50 mg/ml, 5 ml № 5, № 10, № 100
Solution for injections
Active ingredient
Tranexamic acid
Pharmacotherapeutic group

Agents affecting blood system and hemapoiesis

More
50 mg/ml, 5 ml № 5, № 10, № 100 B02AA02
Tranexamic acid
 
Tranexamic acid
100 mg/ml, 5 ml № 5, № 10, № 100
Solution for injections
Active ingredient
Tranexamic acid
Pharmacotherapeutic group

Agents affecting blood system and hemapoiesis

More
100 mg/ml, 5 ml № 5, № 10, № 100 B02AA02
Trombolik-Cardio
 
Trombolik-Cardio
100 mg № 20
Enterosoluble tablets
Active ingredient
Acetylsalicylic acid
Pharmacotherapeutic group

Agents affecting blood system and hemapoiesis

More
100 mg № 20 B01AC06
C.
40
Agents affecting cardio-vascular system
C.

Agents affecting cardio-vascular system

Name Dosage form ATC code
Accordin
 
Accordin
100 mg/ml, 5 ml № 5, № 10, № 100
Solution for injections
Active ingredient
3 (2,2,2-trimethylhydrazinium) propionate dihydrate (meldonium)
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
100 mg/ml, 5 ml № 5, № 10, № 100 С01ЕВ22
Amiodarone
 
Amiodarone
0,2 g № 30
Tablets
Active ingredient
Amiodarone hydrochloride
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
0,2 g № 30 C01BD01
Amlodipine
 
Amlodipine
5 mg № 30
Tablets
Active ingredient
Amlodipine besilate
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
5 mg № 30 C08CA01
Amlodipine
 
Amlodipine
10 mg № 30
Tablets
Active ingredient
Amlodipine besilate
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
10 mg № 30 C08CA01
Amlodipine
 
Amlodipine
5 mg №60
Tablets
Active ingredient
Amlodipine besilate
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
5 mg №60 C08CA01
Amlodipine
 
Amlodipine
5 mg №90
Tablets
Active ingredient
Amlodipine besilate
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
5 mg №90 C08CA01
Amlodipine
 
Amlodipine
10 mg №60
Active ingredient
Amlodipine besilate
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
10 mg №60 C08CA01
Amlodipine
 
Amlodipine
10 mg №90
Active ingredient
Amlodipine besilate
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
10 mg №90 C08CA01
Amlodipine 10
 
Amlodipine 10
10 мг №30
Tablets
Active ingredient
Amlodipine besilate
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
10 мг №30 С08С А01
Amlodipine 10
 
Amlodipine 10
10 mg №60
Tablets
Active ingredient
Amlodipine besilate
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
10 mg №60 С08С А01
Amlodipine 5
 
Amlodipine 5
5 mg №30
Tablets
Active ingredient
Amlodipine besilate
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
5 mg №30 С08С А01
Amlodipine 5
 
Amlodipine 5
5 mg №60
Tablets
Active ingredient
Amlodipine besilate
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
5 mg №60 С08С А01
Anaesthesolum
 
Anaesthesolum
№ 5, № 10
Suppositories
Active ingredient
Benzobarbital, bismuth subgallate, zinc oxide, menthol
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
№ 5, № 10 C05AD
Ascorutin
 
Ascorutin
№ 50, № 800
Tablets
Active ingredient
Ascorbic acid (vitamin C), rutoside
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
№ 50, № 800 C05CA51
Beladonna
 
Beladonna
0,015 g № 10
Rectal suppositories
Active ingredient
Beladonna dense extract
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
0,015 g № 10 C05AX
Bethiolum
 
Bethiolum
№ 10
Rectal suppositories
Active ingredient
Comb drug
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
№ 10 C05AX03
Enalapril
 
Enalapril
0,01 g № 50
Tablets
Active ingredient
Enalapril maleate
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
0,01 g № 50 C09AA02
Enalapril
 
Enalapril
0,01 g № 20
Tablets
Active ingredient
Enalapril maleate
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
0,01 g № 20 C09AA02
Enalapril
 
Enalapril
0,01 g № 90
Tablets
Active ingredient
Enalapril maleate
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
0,01 g № 90 C09AA02
Larginus
 
Larginus
200 mg/ml
Oral solution
Active ingredient
Arginine aspartate
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
100 мл С01E
Lekdona
 
Lekdona
15 mg № 10
Active ingredient
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
15 mg № 10 C05AX
Leksol
 
Leksol
№ 5, № 10
Active ingredient
Benzobarbital, bismuth subgallate, zinc oxide, menthol
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
№ 5, № 10 C05AD
Nicotinic acid
 
Nicotinic acid
50 mg № 50
Tablets
Active ingredient
Nicotinic acid
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
50 mg № 50 C04AC01
Nifedipine
 
Nifedipine
20 mg № 50
Film-coated tablets
Active ingredient
Nifedipine
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
20 mg № 50 C08CA05
Nifedipine
 
Nifedipine
10 mg № 50
Film-coated tablets
Active ingredient
Nifedipine
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
10 mg № 50 C08CA05
Nitroglycerine
 
Nitroglycerine
0,5 mg № 40
Sublingual tablets
Active ingredient
Nitroglycerine 2% on lactose
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
0,5 mg № 40 C01DA02
Nitrogranulong
 
Nitrogranulong
5,2 mg № 10, № 50
Prolonged release tablets
Active ingredient
Nitroglycerine 2% on lactose
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
5,2 mg № 10, № 50 C01DA02
Nitrogranulong
 
Nitrogranulong
2,9 mg № 10, № 50
Prolonged release tablets
Active ingredient
Nitroglycerine 2% on lactose
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
2,9 mg № 10, № 50 C01DA02
Oftalek
 
Oftalek
10 mg/ml 1 ml №10
Solution for injections
Active ingredient
Methylethylpiridinol hydrochloride
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
10 mg/ml 1 ml №10 С05СX
Pentoxifylline
 
Pentoxifylline
100 mg № 10, № 50
Enterosoluble tablets
Active ingredient
Pentoxifylline
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
100 mg № 10, № 50 C04AD03
Propolis
 
Propolis
0,1 g № 5, № 10
Suppositories
Active ingredient
Propolis
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
0,1 g № 5, № 10 C05AX
Riboxin
 
Riboxin
200 mg № 10, № 50
Film-coated tablets
Active ingredient
Riboxin (inosine)
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
200 mg № 10, № 50 C01EB
Spironolactone
 
Spironolactone
25 mg №20
Tablets
Active ingredient
Spironolactone
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
25 mg №20 C03D A01
Spironolactone
 
Spironolactone
50 mg №20
Tablets
Active ingredient
Spironolactone
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
50 mg №20 C03D A01
Spironolactone
 
Spironolactone
100 mg №20
Tablets
Active ingredient
Spironolactone
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
100 mg №20 C03D A01
Spironolactone
 
Spironolactone
25 mg №50
Active ingredient
Spironolactone
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
25 mg №50 C03D A01
Spironolactone
 
Spironolactone
50 mg №50
Tablets
Active ingredient
Spironolactone
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
50 mg №50 C03D A01
Spironolactone
 
Spironolactone
100 mg №50
Tablets
Active ingredient
Spironolactone
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
100 mg №50 C03D A01
Spironolactone
 
Spironolactone
100 mg №30
Tablets
Active ingredient
Spironolactone
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
100 mg №30 C03D A01
Spironolactone
 
Spironolactone
50 mg №30
Tablets
Active ingredient
Spironolactone
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
50 mg №30 C03D A01
Spironolactone
 
Spironolactone
25 mg №30
Tablets
Active ingredient
Spironolactone
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
25 mg №30 C03D A01
Torasemide
 
Torasemide
5 mg/ml 2 ml, 4 ml № 5, № 10, № 100
Solution for injections
Active ingredient
Torasemide
Pharmacotherapeutic group

Agents affecting cardio-vascular system

More
5 mg/ml 2 ml, 4 ml № 5, № 10, № 100 C03CA04
D.
6
Dermatological agents
D.

Dermatological agents

Name Dosage form ATC code
Aecol
 
Aecol
50 ml № 1
Oil solution
Active ingredient
Retinol (vit A), tocopherol (vit E), menadione (vit K3), betacarotene
Pharmacotherapeutic group

Dermatological agents

More
50 ml № 1 D03AX
Aecol
 
Aecol
50 ml, 100 ml
Active ingredient
Retinol acetate, alpha-tocopheryl acetate, menadione, beta-carotene
Pharmacotherapeutic group

Dermatological agents

More
50 ml, 100 ml D03АX
Aecol
 
Aecol
100 ml
Oil solution
Active ingredient
Retinol (vit A), tocopherol (vit E), menadione (vit K3), betacarotene
Pharmacotherapeutic group

Dermatological agents

More
100 ml № 1 D03AX
Iodine Pechaevskiy
 
Iodine Pechaevskiy
10 % 30 ml № 1
Solution for external administration
Active ingredient
Povidone/Iodine
Pharmacotherapeutic group

Dermatological agents

More
10 % 30 ml № 1 D08AG02
Iodine Pechaevskiy
 
Iodine Pechaevskiy
10 % 120 ml № 1
Solution for external administration
Active ingredient
Povidone/Iodine
Pharmacotherapeutic group

Dermatological agents

More
10 % 120 ml № 1 D08AG02
Iodine Pechaevskiy
 
Iodine Pechaevskiy
10 % 1000 ml № 1
Solution for external administration
Active ingredient
Povidone/Iodine
Pharmacotherapeutic group

Dermatological agents

More
10 % 1000 ml № 1 D08AG02
Naftiderile
 
Naftiderile
10 ml № 1
Dermal solution
Active ingredient
Naphthyfin hydrochloride
Pharmacotherapeutic group

Dermatological agents

More
10 ml № 1 D01AE22
G.
19
Agents affecting genitourinary system and reproductive hormones
G.

Agents affecting genitourinary system and reproductive hormones

Name Dosage form ATC code
Chinofucin
 
Chinofucin
0,015 g № 5, № 10
Vaginal suppositories
Active ingredient
Chlorquinaldol
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
0,015 g № 5, № 10 G01AC03
Eucolec
 
Eucolec
0,05 g № 5, № 10
Suppositories
Active ingredient
Chlorophyllipt dense extract
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
0,05 g № 5, № 10 G01AX
Klioron
 
Klioron
16 mg № 10
Vaginal suppositories
Active ingredient
Chlorhexidine digluconate
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
16 mg № 10 G01AX
Klioron V
 
Klioron V
16 mg № 10
Active ingredient
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
16 mg № 10 G01AX
Lekfucin
 
Lekfucin
15 mg № 5, № 10
Active ingredient
Chlorquinaldol
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
15 mg № 5, № 10 G01AС03
Leknazole
 
Leknazole
150 mg № 3
Active ingredient
Econazole nitrate
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
150 mg № 3 G01АF05
Lekvolek
 
Lekvolek
50 mg № 5, № 10
Active ingredient
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
50 mg № 5, № 10 G01AX
Levoklek
 
Levoklek
50 mg № 5, № 10
Active ingredient
Chlorophyllipt dense extract
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
50 mg № 5, № 10 G01AX
Omix
 
Omix
0,4 mg № 10, № 30
Hard capsules
Active ingredient
Tamsulosin hydrochloride
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
0,4 mg № 10, № 30 G04CA02
Omix
 
Omix
0.4 mg № 10, № 30
Active ingredient
Tamsulosin hydrochloride
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
0.4 mg № 10, № 30 G04C A02
Potentiale
 
Potentiale
100 mg № 1
Film-coated tablets
Active ingredient
Sildenafil citrate
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
100 mg № 1 G04BE03
Potentiale
 
Potentiale
50 mg № 1
Film-coated tablets
Active ingredient
Sildenafil citrate
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
50 mg № 1 G04BE03
Potentiale
 
Potentiale
50 mg № 2
Film-coated tablets
Active ingredient
Sildenafil citrate
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
50 mg № 2 G04BE03
Potentiale
 
Potentiale
50 mg №4
Film-coated tablets
Active ingredient
Sildenafil citrate
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
50 mg №4 G04BE03
Potentiale
 
Potentiale
100 mg №2
Film-coated tablets
Active ingredient
Sildenafil citrate
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
100 mg №2 G04BE03
Potentiale
 
Potentiale
100 mg №4
Film-coated tablets
Active ingredient
Sildenafil citrate
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
100 mg №4 G04BE03
Povidin
 
Povidin
0,3 g № 5, № 10
Vaginal suppositories
Active ingredient
Povidone/Iodine
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
0,3 g № 5, № 10 G01AX11
Prostan
 
Prostan
5 mg № 10, № 30
Film-coated tablets
Active ingredient
Finasteride
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
5 mg № 10, № 30 G04CB01
Prostatilen
 
Prostatilen
0,03 g № 10
Rectal suppositories
Active ingredient
Prostatilen
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
0,03 g № 10 G04CX
Prostatilen
 
Prostatilen
2 ml № 5, № 10
Solution for injections
Active ingredient
Prostatilen
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
2 ml № 5, № 10 G04СX
Prostatilen
 
Prostatilen
0,03 g №5
Rectal suppositories
Active ingredient
Prostatilen
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
0,03 g №5 G04CX
Prostatilen-Zinc
 
Prostatilen-Zinc
№ 5
Rectal suppositories
Active ingredient
Comb drug
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
№ 5 G04CX
Prostatilen-Zinc
 
Prostatilen-Zinc
№10
Rectal suppositories
Active ingredient
Comb drug
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
№10 G04CX
Santekvin
 
Santekvin
0,15 g № 3
Vaginal suppositories
Active ingredient
Econazole nitrate
Pharmacotherapeutic group

Agents affecting genitourinary system and reproductive hormones

More
0,15 g № 3 G01AF05
H.
2
Hormone drugs for systemic use
H.

Hormone drugs for systemic use

Name Dosage form ATC code
Bemedozon
 
Bemedozon
4 mg/ml, 1 ml № 5, № 10, № 100
Solution for injections
Active ingredient
Betamethasone
Pharmacotherapeutic group

Hormone drugs for systemic use

More
4 mg/ml, 1 ml № 5, № 10, № 100 Н02АВ01
Dexamethasone
 
Dexamethasone
4 mg/ml, 1 ml № 5
Solution for injections
Active ingredient
Dexamethasone sodium phosphate
Pharmacotherapeutic group

Hormone drugs for systemic use

More
4 mg/ml, 1 ml № 5 H02AB02
Lekthasone
 
Lekthasone
4 mg/1 ml № 5, № 100
Active ingredient
Dexamethasone sodium phosphate
Pharmacotherapeutic group

Hormone drugs for systemic use

More
4 mg/1 ml № 5, № 100 H02AB02
J.
62
Antimicrobial agents for systemic use
J.

Antimicrobial agents for systemic use

Name Dosage form ATC code
Aciclovir
 
Aciclovir
0,2 g № 10, № 20
Tablets
Active ingredient
Aciclovir
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
0,2 g № 10, № 20 J05AB01
Amicacin sulfate
 
Amicacin sulfate
50 mg/ml, 2 ml № 1
Solution for injections
Active ingredient
Amikacin sulfate
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
50 mg/ml, 2 ml № 1 J01GB06
Amikacin sulfate
 
Amikacin sulfate
250 mg/ml, 2 ml № 1
Solution for injections
Active ingredient
Amikacin sulfate
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
250 mg/ml, 2 ml № 1 J01GB06
Amikacin sulfate
 
Amikacin sulfate
250 mg/ml, 4 ml № 1
Solution for injections
Active ingredient
Amikacin sulfate
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
250 mg/ml, 4 ml № 1 J01GB06
Cefazolin
 
Cefazolin
1,0 g № 5
Powder for solution for injections
Active ingredient
Cefazolin sodium
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 g № 5 J01DB04
Cefazolin
 
Cefazolin
1,0 g № 1
Powder for solution for injections
Active ingredient
Cefazolin sodium
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 g № 1 J01DB04
Cefazolin 1000
 
Cefazolin 1000
1,0 g № 5
Powder for solution for injections
Active ingredient
Cefazolin sodium
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 g № 5 J01DB04
Cefazolin 1000
 
Cefazolin 1000
1,0 g № 1
Powder for solution for injections
Active ingredient
Cefazolin sodium
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 g № 1 J01DB04
Cefazolin combi
 
Cefazolin combi
0,5 g № 1, № 10, № 50
Powder for solution for injections
Active ingredient
Cefazolin sodium
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
0,5 g № 1, № 10, № 50 J01DB04
Cefepime
 
Cefepime
1 g № 1
Powder for solution for injections
Active ingredient
Cefepime hydrochloride
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1 g № 1 J01DE01
Cefepime with solvent
 
Cefepime with solvent
1,0 г № 1
Powder for solution for injections
Active ingredient
Cefepime hydrochloride
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 г № 1 J01DE01
Cefotaxime
 
Cefotaxime
1,0 g № 1
Powder for solution for injections
Active ingredient
Cefotaxime sodium
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 g № 1 J01DD01
Cefotaxime
 
Cefotaxime
1,0 g № 5
Powder for solution for injections
Active ingredient
Cefotaxime sodium
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 g № 5 J01DD01
Cefotaxime
 
Cefotaxime
1,0 g № 1
Powder for solution for injections
Active ingredient
Cefotaxime
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 g № 1 J01DD01
Cefotaxime
 
Cefotaxime
1,0 g № 50
Powder for solution for injections
Active ingredient
Cefotaxime
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 g № 50 J01DD01
Cefotaxime
 
Cefotaxime
1,0 g № 5
Powder for solution for injections
Active ingredient
Cefotaxime
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 g № 5 J01DD01
Cefotaxime + Water for injection
 
Cefotaxime + Water for injection
1 vial and 1 ampoule
Powder for solution for injections
Active ingredient
Cefotaxime
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1 vial and 1 ampoule J01D D01
Cefotaxime combi
 
Cefotaxime combi
0,5 g №1
Powder for solution for injections
Active ingredient
Cefotaxime
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
0,5 g №1 J01DD01
Ceftazidime
 
Ceftazidime
1,0 g № 1, № 5, № 50
Powder for solution for injections
Active ingredient
Ceftazidime pentahydrate
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 g № 1, № 5, № 50 J01DD02
Ceftriaxone
 
Ceftriaxone
1,0 g №50
Powder for solution for injections
Active ingredient
Ceftriaxone sodium
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 g №50 J01DD04
Ceftriaxone
 
Ceftriaxone
1,0 g №50
Powder for solution for injections
Active ingredient
Ceftriaxone sodium
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 g №50 J01DD04
Ceftriaxone
 
Ceftriaxone
1,0 g № 1
Solution for injections
Active ingredient
Ceftriaxone sodium
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 g № 1 J01DD04
Ceftriaxone
 
Ceftriaxone
1,0 g № 5
Solution for injections
Active ingredient
Ceftriaxone sodium
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 g № 5 J01DD04
Ceftriaxone
 
Ceftriaxone
1,0 g №1
Powder for solution for injections
Active ingredient
Ceftriaxone sodium
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 g №1 J01DD04
Ceftriaxone
 
Ceftriaxone
1,0 g №5
Powder for solution for injections
Active ingredient
Ceftriaxone sodium
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 g №5 J01DD04
Ceftriaxone + Lidocaine
 
Ceftriaxone + Lidocaine
1 vial and 1 ampoule
Powder for solution for injections
Active ingredient
Ceftriaxone
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1 vial and 1 ampoule J01D D04
Ceftriaxone + Water for injection
 
Ceftriaxone + Water for injection
1 vial and 1 ampoule
Powder for solution for injections
Active ingredient
Ceftriaxone
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1 vial and 1 ampoule J01D D04
Ceftriaxone 500
 
Ceftriaxone 500
0,5 g № 1, № 10, № 50
Powder for solution for injections
Active ingredient
Ceftriaxone
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
0,5 g № 1, № 10, № 50 J01D D04
Cefuroxime
 
Cefuroxime
0,75 g №1
Powder for solution for injections
Active ingredient
Cefuroxime
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
0,75 g №1 J01DC02
Cefuroxime
 
Cefuroxime
0,75 g №1
Powder for solution for injections
Active ingredient
Cefuroxime
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
0,75 g №1 J01DC02
Cefuroxime
 
Cefuroxime
1,5 g №1
Powder for solution for injections
Active ingredient
Cefuroxime
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,5 g №1 J01DC02
Cefuroxime
 
Cefuroxime
1,5 g № 1
Powder for solution for injections
Active ingredient
Cefuroxime
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,5 g № 1 J01DС02
Cefuroxime + Water for injection
 
Cefuroxime + Water for injection
1 vial and 1 ampoule
Powder for solution for injections
Active ingredient
Cefuroxime
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1 vial and 1 ampoule J01D С02
Cilpen
 
Cilpen
500 mg/500 mg № 1
Powder for solution for infusion
Active ingredient
Imipenem and cilastatin
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
500 mg/500 mg № 1 J01DH51
Cilpen
 
Cilpen
500 mg/500 mg № 10
Powder for solution for infusion
Active ingredient
Imipenem and cilastatin
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
500 mg/500 mg № 10 J01DH51
Ciprofloxacin
 
Ciprofloxacin
500 mg № 10
Film-coated tablets
Active ingredient
Ciprofloxacin hydrochloride
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
500 mg № 10 J01MA02
Ciprofloxacin
 
Ciprofloxacin
250 mg № 10
Film-coated tablets
Active ingredient
Ciprofloxacin hydrochloride
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
250 mg № 10 J01MA02
Cycloserine
 
Cycloserine
250 mg № 30
Hard capsules
Active ingredient
Cycloserine
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
250 mg № 30 J04AВ01
Fluconazole
 
Fluconazole
150 mg №2
Film-coated tablets
Active ingredient
Fluconazole
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
150 mg №2 J02AC01
Fluconazole
 
Fluconazole
50 mg № 10
Film-coated tablets
Active ingredient
Fluconazole
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
50 mg № 10 J02AC02
Fluconazole
 
Fluconazole
100 mg № 10
Film-coated tablets
Active ingredient
Fluconazole
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
100 mg № 10 J02AC01
Fluconazole
 
Fluconazole
150 mg № 1
Film-coated tablets
Active ingredient
Fluconazole
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
150 mg № 1 J02AC01
Lamivudine
 
Lamivudine
10 mg/ml, 240 ml № 1
Oral solution
Active ingredient
Lamivudine
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
10 mg/ml, 240 ml № 1 J05А F05
Lamivudine
 
Lamivudine
150 mg № 60
Film-coated tablets
Active ingredient
Lamivudine
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
150 mg № 60 J05AF05
Lazivudine
 
Lazivudine
№ 60
Film-coated tablets
Active ingredient
Comb drug
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
№ 60 J05AR01
Lekcef + water for injections
 
Lekcef + water for injections
1 vial and 1 ampoule
Active ingredient
Ceftriaxone
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1 vial and 1 ampoule J01DD04
Lekcef + Water for injections
 
Lekcef + Water for injections
1 vial and 1 ampoule
Active ingredient
Ceftriaxone
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1 vial and 1 ampoule J01DD04
Lekcin
 
Lekcin
200 mg № 10
Active ingredient
Ofloxacin
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
200 mg № 10 J01MA01
Lekfazolin
 
Lekfazolin
1,0 g № 1
Active ingredient
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 g № 1 J01DB04
Lektaxime
 
Lektaxime
1.0 g № 1
Active ingredient
Cefotaxime
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1.0 g № 1 J01DD01
Lektaxime + Water for injection
 
Lektaxime + Water for injection
1 vial and 1 ampoule
Active ingredient
Cefotaxime
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1 vial and 1 ampoule J01DD01
Levofloxacin
 
Levofloxacin
250 mg № 10
Film-coated tablets
Active ingredient
Levofloxacin hemihydrate
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
250 mg № 10 J01MA12
Levofloxacin
 
Levofloxacin
500 mg № 10
Film-coated tablets
Active ingredient
Levofloxacin hemihydrate
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
500 mg № 10 J01MA12
Meropenem
 
Meropenem
1,0 g №1
Powder for solution for injections
Active ingredient
Meropenem trihydrate
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 g №1 J01DH02
Meropenem
 
Meropenem
1,0 g № 1
Powder for solution for injections
Active ingredient
Meropenem trihydrate
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 g № 1 J01DH02
Moxifloxacin
 
Moxifloxacin
400 mg №5
Film-coated tablets
Active ingredient
Moxifloxacin
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
400 mg №5 J01MA14
Moxifloxacin
 
Moxifloxacin
400 мг №7
Film-coated tablets
Active ingredient
Moxifloxacin
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
400 мг №7 J01MA14
Moxifloxacin
 
Moxifloxacin
400 mg №10
Film-coated tablets
Active ingredient
Moxifloxacin
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
400 mg №10 J01MA14
Nitroxoline
 
Nitroxoline
50 mg № 10, № 50
Film-coated tablets
Active ingredient
Nitroxoline
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
50 mg № 10, № 50 J01XX07
Ofloxacin
 
Ofloxacin
0,2 g № 10
Tablets
Active ingredient
Ofloxacin
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
0,2 g № 10 J01MA01
Promocef
 
Promocef
1,0 g № 1, № 5
Powder for solution for injections
Active ingredient
Ceftriaxone sodium
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
1,0 g № 1, № 5 J01DD04
Protech
 
Protech
250 mg № 50, № 500
Film-coated tablets
Active ingredient
Prothionamide
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
250 mg № 50, № 500 J04AD01
Sodium aminosalicylate
 
Sodium aminosalicylate
0,8 g/1g, 100 g № 1
Enterosoluble granules
Active ingredient
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
0,8 g/1g, 100 g № 1 J04AA02
Terizidone
 
Terizidone
250 mg № 10
Hard capsules
Active ingredient
Terizidone
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
250 mg № 10 J04AK03
Triseptol
 
Triseptol
100 mg/20 mg № 20
Tablets
Active ingredient
Comb drug
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
100 mg/20 mg № 20 J01EE01
Triseptol
 
Triseptol
400 mg/80 mg № 20
Tablets
Active ingredient
Comb drug
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
400 mg/80 mg № 20 J01EE01
Urosept
 
Urosept
0,2 g № 10
Suppositories
Active ingredient
Pipemidic acid trihydrate
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
0,2 g № 10 J01MB04
Zidovudine
 
Zidovudine
10 mg/ml 200 ml
Oral solution
Active ingredient
Zidovudine
Pharmacotherapeutic group

Antimicrobial agents for systemic use

More
10 mg/ml 200 ml J05AF01
L.
0
Antineoplastic and immunomodulating agents
L.
Antineoplastic and immunomodulating agents
M.
16
Agents affecting musculo-skeletal system
M.

Agents affecting musculo-skeletal system

Name Dosage form ATC code
Blockpain
 
Blockpain
30 mg/ml, 1 ml №10
Solution for injections
Active ingredient
Ketorolac tromethamine
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
30 mg/ml, 1 ml №10 M01AB15
Desket
 
Desket
25 mg/ml, 2 ml № 10
Solution for injections
Active ingredient
Dexketoprofen
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
25 mg/ml, 2 ml № 10 M01AE17
Diclofenac
 
Diclofenac
0,1 g № 10
Rectal suppositories
Active ingredient
Diclofenac sodium
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
0,1 g № 10 M01AB05
Diclofenac
 
Diclofenac
25 mg/ml, 3 ml №5
Solution for injections
Active ingredient
Diclofenac sodium
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
25 mg/ml, 3 ml №5 M01AB05
Ibuprofen
 
Ibuprofen
200 mg № 50
Film-coated tablets
Active ingredient
Ibuprofen
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
200 mg № 50 M01AE01
Ibuprofen 200
 
Ibuprofen 200
200 mg № 10, № 50, № 900
Active ingredient
Ibuprofen
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
200 mg № 10, № 50, № 900 М01А Е01
Ibuprofen 400
 
Ibuprofen 400
400 mg № 10, №20, № 50
Active ingredient
Ibuprofen
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
400 mg № 10, №20, № 50 M01A E01
Ibuprofen 400
 
Ibuprofen 400
400 mg № 50
Film-coated tablets
Active ingredient
Ibuprofen
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
400 mg № 50 М01АЕ01
Ibuprofen 400
 
Ibuprofen 400
400 mg №10
Film-coated tablets
Active ingredient
Ibuprofen
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
400 mg №10 М01АЕ01
Ibuprofen 400
 
Ibuprofen 400
400 mg №20
Film-coated tablets
Active ingredient
Ibuprofen
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
400 mg №20 М01АЕ01
Inflamine
 
Inflamine
0,015 g № 10
Rectal suppositories
Active ingredient
Meloxicam
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
0,015 g № 10 M01AC06
Inflamine
 
Inflamine
15 mg/1,5 ml in ampoule № 5
Solution for injections
Active ingredient
Meloxicam
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
15 mg/1,5 ml in ampoule № 5 М01АС06
Ketalgin
 
Ketalgin
0,01 g, № 10
Tablets
Active ingredient
Ketorolac tromethamine
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
0,01 g, № 10 M01AB15
Lekfenac
 
Lekfenac
100 mg № 10
Active ingredient
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
100 mg № 10 M01AB05
Lekfenac
 
Lekfenac
75 mg/3 ml № 5, № 100
Active ingredient
Diclofenac sodium
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
75 mg/3 ml № 5, № 100 М01АВ05
Lektalgin
 
Lektalgin
30 mg/ml 1 ml № 10, № 100
Active ingredient
Ketorolac tromethamine
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
30 mg/ml 1 ml № 10, № 100 M01AB15
Meloxicam
 
Meloxicam
0,0075 g № 10 ,№ 20
Tablets
Active ingredient
Meloxicam
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
0,0075 g № 10 ,№ 20 M01AC06
Meloxicam
 
Meloxicam
0,015 g № 10, № 20
Tablets
Active ingredient
Meloxicam
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
0,015 g № 10, № 20 M01AC06
Nimesulide
 
Nimesulide
0,1 g № 10, № 30
Tablets
Active ingredient
Nimesulide
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
0,1 g № 10, № 30 M01AX17
Ortophen
 
Ortophen
25 mg № 10, № 30
Enterosoluble tablets
Active ingredient
Diclofenac sodium
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
25 mg № 10, № 30 M01AB05
Zoledronic acid
 
Zoledronic acid
0,8 mg/ml, 5 ml № 1, № 5, № 10
Concentrate for solution for infusion
Active ingredient
Zoledronic acid
Pharmacotherapeutic group

Agents affecting musculo-skeletal system

More
0,8 mg/ml, 5 ml № 1, № 5, № 10 М05ВА08
N.
41
Agents affecting the nervous system
N.

Agents affecting the nervous system

Name Dosage form ATC code
Acetylsalicylic acid
 
Acetylsalicylic acid
500 mg № 10
Tablets
Active ingredient
Acetylsalicylic acid
Pharmacotherapeutic group

Agents affecting the nervous system

More
500 mg № 10 N02BA01
Alzhmerat
 
Alzhmerat
600 mg/7 ml № 10
Oral solution
Active ingredient
Choline alfoscerate
Pharmacotherapeutic group

Agents affecting the nervous system

More
600 mg/7 ml № 10 N07A X02
Alzhmerat
 
Alzhmerat
250 mg/ml, 4 ml № 5
Solution for injections
Active ingredient
Choline alfoscerate
Pharmacotherapeutic group

Agents affecting the nervous system

More
250 mg/ml, 4 ml № 5 N07AX02
Amitriptylline
 
Amitriptylline
25 mg № 50, № 1000
Film-coated tablets
Active ingredient
Amitriptylline
Pharmacotherapeutic group

Agents affecting the nervous system

More
25 mg № 50, № 1000 N06AA09
Analgin
 
Analgin
500 mg/ml, 2 ml № 10
Solution for injections
Active ingredient
Metamizole sodium
Pharmacotherapeutic group

Agents affecting the nervous system

More
500 mg/ml, 2 ml № 10 N02BB02
Analgin for children
 
Analgin for children
0,1 g № 10
Rectal suppositories
Active ingredient
Metamizole sodium
Pharmacotherapeutic group

Agents affecting the nervous system

More
0,1 g № 10 N02BB02
Analgin for children
 
Analgin for children
0,25 g № 10
Rectal suppositories
Active ingredient
Metamizole sodium
Pharmacotherapeutic group

Agents affecting the nervous system

More
0,25 g № 10 N02BB02
Azaleptol
 
Azaleptol
100 mg №50
Tablets
Active ingredient
Clozapine
Pharmacotherapeutic group

Agents affecting the nervous system

More
100 mg №50 N05AH02
Azaleptol
 
Azaleptol
25 mg № 50
Tablets
Active ingredient
Clozapine
Pharmacotherapeutic group

Agents affecting the nervous system

More
25 mg № 50 N05AH02
Barviton
 
Barviton
5 mg/ml, 2 ml № 10
Solution for injections
Active ingredient
Vinpocetine
Pharmacotherapeutic group

Agents affecting the nervous system

More
5 mg/ml, 2 ml № 10 N06BX18
Carbamazepine
 
Carbamazepine
200 mg №20
Tablets
Active ingredient
Carbamazepine
Pharmacotherapeutic group

Agents affecting the nervous system

More
200 mg №20 N03AF01
Carbamazepine
 
Carbamazepine
200 mg № 50
Tablets
Active ingredient
Carbamazepine
Pharmacotherapeutic group

Agents affecting the nervous system

More
200 mg № 50 N03AF01
Cilityn
 
Cilityn
250 mg/ml, 4 ml № 5, № 10, № 100
Solution for injections
Active ingredient
Citicoline
Pharmacotherapeutic group

Agents affecting the nervous system

More
250 mg/ml, 4 ml № 5, № 10, № 100 N06BX06
Cinnarizine
 
Cinnarizine
0,025 g № 25, № 50
Tablets
Active ingredient
Cinnarizine
Pharmacotherapeutic group

Agents affecting the nervous system

More
0,025 g № 25, № 50 N07CA02
Cylityne
 
Cylityne
100 mg, 30 ml
Oral solution
Active ingredient
Citicoline
Pharmacotherapeutic group

Agents affecting the nervous system

More
100 mg, 30 ml N06BX06
Epigaba
 
Epigaba
300 mg №100
Hard capsules
Active ingredient
Gabapentin
Pharmacotherapeutic group

Agents affecting the nervous system

More
300 mg №100 N03AX12
Epigaba
 
Epigaba
300 mg № 20
Hard capsules
Active ingredient
Gabapentin
Pharmacotherapeutic group

Agents affecting the nervous system

More
300 mg № 20 N03AX12
Ipidacord
 
Ipidacord
15 mg/ml 1 ml №10
Solution for injections
Active ingredient
Ipidacrine hydrochloride
Pharmacotherapeutic group

Agents affecting the nervous system

More
15 mg/ml 1 ml №10 N07АА
Ipidacord
 
Ipidacord
5 mg/ml 1 ml №10, №100
Solution for injections
Active ingredient
Ipidacrine hydrochloride
Pharmacotherapeutic group

Agents affecting the nervous system

More
5 mg/ml 1 ml №10, №100 N07АА
Kineyron
 
Kineyron
75 мг №21
Hard capsules
Active ingredient
Pharmacotherapeutic group

Agents affecting the nervous system

More
75 мг №21 N03A X16
Kineyron
 
Kineyron
150 мг №21
Hard capsules
Active ingredient
Pharmacotherapeutic group

Agents affecting the nervous system

More
150 мг №21 N03A X16
Kineyron
 
Kineyron
300 мг №21
Hard capsules
Active ingredient
Pharmacotherapeutic group

Agents affecting the nervous system

More
300 мг №21 N03A X16
Kineyron
 
Kineyron
75 mg №56
Hard capsules
Active ingredient
Pharmacotherapeutic group

Agents affecting the nervous system

More
75 mg №56 N03A X16
Kineyron
 
Kineyron
150 mg №56
Hard capsules
Active ingredient
Pharmacotherapeutic group

Agents affecting the nervous system

More
150 mg №56 N03A X16
Kineyron
 
Kineyron
300 mg №56
Hard capsules
Active ingredient
Pharmacotherapeutic group

Agents affecting the nervous system

More
300 mg №56 N03A X16
Leknizine
 
Leknizine
0,025 g № 10, № 50
Active ingredient
Cinnarizine
Pharmacotherapeutic group

Agents affecting the nervous system

More
0,025 g № 10, № 50 N07CA02
Lektil 200
 
Lektil 200
200 mg №50
Active ingredient
Carbamazepine
Pharmacotherapeutic group

Agents affecting the nervous system

More
200 mg №50 N03A F01
Lidocaine
 
Lidocaine
20 mg/ml, 2 ml in ampoules № 10
Solution for injections
Active ingredient
Lidocaine hydrochloride
Pharmacotherapeutic group

Agents affecting the nervous system

More
20 mg/ml, 2 ml in ampoules № 10 N01BB02
Lidocaine
 
Lidocaine
10 mg/ml, 3,5 ml № 10
Solution for injections
Active ingredient
Lidocaine hydrochloride
Pharmacotherapeutic group

Agents affecting the nervous system

More
10 mg/ml, 3,5 ml № 10 N01BВ02
Nalbuphine
 
Nalbuphine
10 mg/ml 1 ml №10
Solution for injections
Active ingredient
Nalbuphine hydrochloride
Pharmacotherapeutic group

Agents affecting the nervous system

More
10 mg/ml 1 ml №10 N02AF02
Nalbuphine
 
Nalbuphine
10 mg/ml 2 ml №5
Solution for injections
Active ingredient
Nalbuphine hydrochloride
Pharmacotherapeutic group

Agents affecting the nervous system

More
10 mg/ml 2 ml №5 N02AF02
Novocaine
 
Novocaine
5 mg/ml, 5 ml № 10
Solution for injections
Active ingredient
Procaine hydrochloride
Pharmacotherapeutic group

Agents affecting the nervous system

More
5 mg/ml, 5 ml № 10 N01BA02
Paracetamol
 
Paracetamol
500 mg №10, №20, №50
Tablets
Active ingredient
Paracetamol
Pharmacotherapeutic group

Agents affecting the nervous system

More
500 mg №10, №20, №50 N02B E01
Piracetam
 
Piracetam
200 mg/mg, 5 ml № 10
Solution for injections
Active ingredient
Piracetam
Pharmacotherapeutic group

Agents affecting the nervous system

More
200 mg/mg, 5 ml № 10 N06BX03
Tet 36.6 RAPID with acacia flavour
 
Tet 36.6 RAPID with acacia flavour
23 g № 5, № 10
Powder for oral solution
Active ingredient
Paracetamol, phenylephrine hydrochloride, pheniramine maleate, ascorbic acid
Pharmacotherapeutic group

Agents affecting the nervous system

More
23 g № 5, № 10 N02BЕ51
Tet 36.6 RAPID with lemon flavour
 
Tet 36.6 RAPID with lemon flavour
23 g № 5, № 10
Powder for oral solution
Active ingredient
Paracetamol, phenylephrine hydrochloride, pheniramine maleate, ascorbic acid
Pharmacotherapeutic group

Agents affecting the nervous system

More
23 g № 5, № 10 N02BЕ51
Tеt 36.6 MAXI with lemon flavour
 
Tеt 36.6 MAXI with lemon flavour
23 g № 5, № 10
Powder for oral solution
Active ingredient
Paracetamol, phenylephrine hydrochloride, pheniramine maleate, ascorbic acid
Pharmacotherapeutic group

Agents affecting the nervous system

More
23 g № 5, № 10 N02BЕ51
Tеt 36.6 MAXI with raspberry flavour
 
Tеt 36.6 MAXI with raspberry flavour
23 g № 5, № 10
Powder for oral solution
Active ingredient
Paracetamol, phenylephrine hydrochloride, pheniramine maleate, ascorbic acid
Pharmacotherapeutic group

Agents affecting the nervous system

More
23 g № 5, № 10 N02BE51
Tеt 36.6 with acacia flavour
 
Tеt 36.6 with acacia flavour
13,1 g № 5, № 10
Powder for oral solution
Active ingredient
Paracetamol, pheniramine maleate, ascorbic acid
Pharmacotherapeutic group

Agents affecting the nervous system

More
13,1 g № 5, № 10 N02BE51
Venocor
 
Venocor
50 mg/ml 2 ml № 10
Solution for injections
Active ingredient
Ethylmethylhydroxypyridine succinate
Pharmacotherapeutic group

Agents affecting the nervous system

More
50 mg/ml 2 ml № 10 N07XX
Venocor
 
Venocor
50 mg/ml, 5 ml № 5
Solution for injections
Active ingredient
Ethylmethylhydroxypyridine succinate
Pharmacotherapeutic group

Agents affecting the nervous system

More
50 mg/ml, 5 ml № 5 N07XX
Vinpocetin
 
Vinpocetin
0,005 g № 30, № 50
Tablets
Active ingredient
Vinpocetine
Pharmacotherapeutic group

Agents affecting the nervous system

More
0,005 g № 30, № 50 N06BX18
P.
2
Anti-parasite agents, insecticides and repellents
P.

Anti-parasite agents, insecticides and repellents

Name Dosage form ATC code
PerMin
 
PerMin
50 g
Solution for external administration
Active ingredient
Permethrin
Pharmacotherapeutic group

Anti-parasite agents, insecticides and repellents

More
50 g -
PerMin NEW
 
PerMin NEW
50 ml
Solution for external administration
Active ingredient
Permethrin
Pharmacotherapeutic group

Anti-parasite agents, insecticides and repellents

More
50 ml -
R.
17
Agents affecting the respiratory system
R.

Agents affecting the respiratory system

Name Dosage form ATC code
Alergolik
 
Alergolik
5 mg № 10
Film-coated tablets
Active ingredient
Levocetirizine
Pharmacotherapeutic group

Agents affecting the respiratory system

More
5 mg № 10 R06AE09
Alergolik
 
Alergolik
5 mg/ml, 10 ml № 1
Oral drops
Active ingredient
Levocetirizine
Pharmacotherapeutic group

Agents affecting the respiratory system

More
5 mg/ml, 10 ml № 1 R06AE09
Alergolik
 
Alergolik
5 mg № 30
Film-coated tablets
Active ingredient
Levocetirizine
Pharmacotherapeutic group

Agents affecting the respiratory system

More
5 mg № 30 R06AE09
Ambroxol
 
Ambroxol
0,03 g № 20
Tablets
Active ingredient
Ambroxol hydrochloride
Pharmacotherapeutic group

Agents affecting the respiratory system

More
0,03 g № 20 R05CB06
Desloratadine
 
Desloratadine
0,5 mg/ml, 60 ml № 1
Syrup
Active ingredient
Desloratadine
Pharmacotherapeutic group

Agents affecting the respiratory system

More
0,5 mg/ml, 60 ml № 1 R06AX27
Desloratadine
 
Desloratadine
5 mg № 10, № 30
Film-coated tablets
Active ingredient
Desloratadine
Pharmacotherapeutic group

Agents affecting the respiratory system

More
5 mg № 10, № 30 R06AX27
Ketotifen
 
Ketotifen
0,001 g № 10
Tablets
Active ingredient
Ketotifen fumarate
Pharmacotherapeutic group

Agents affecting the respiratory system

More
0,001 g № 10 R06AX17
Ketotifen
 
Ketotifen
0,001 g № 30
Tablets
Active ingredient
Ketotifen fumarate
Pharmacotherapeutic group

Agents affecting the respiratory system

More
0,001 g № 30 R06AX17
Loratadine
 
Loratadine
0,01 g № 20
Tablets
Active ingredient
Loratadine
Pharmacotherapeutic group

Agents affecting the respiratory system

More
0,01 g № 20 R06AX13
Loratadine
 
Loratadine
0,01 g № 10
Tablets
Active ingredient
Loratadine
Pharmacotherapeutic group

Agents affecting the respiratory system

More
0,01 g № 10 R06AX13
Lorolik
 
Lorolik
50 ml
Oral spray
Active ingredient
Hexetidine, choline salicylate, chlorobutanol hemihydrate
Pharmacotherapeutic group

Agents affecting the respiratory system

More
50 ml R02AA20
Lorolik
 
Lorolik
125 ml
Solution for oral cavity
Active ingredient
Hexetidine, choline salicylate, chlorobutanol hemihydrate
Pharmacotherapeutic group

Agents affecting the respiratory system

More
125 ml R02AA20
Mucolik
 
Mucolik
2%, 125 ml
Syrup
Active ingredient
Carbocisteine
Pharmacotherapeutic group

Agents affecting the respiratory system

More
2%, 125 ml R05CB03
Mucolik
 
Mucolik
5%, 125 ml
Syrup
Active ingredient
Carbocisteine
Pharmacotherapeutic group

Agents affecting the respiratory system

More
5%, 125 ml R05СВ03
Mucosol
 
Mucosol
7,5 мг/мл 2 ml №10
Solution for infusions
Active ingredient
Ambroxol hydrochloride
Pharmacotherapeutic group

Agents affecting the respiratory system

More
7,5 мг/мл 2 ml №10 R05C B06
Mucosol
 
Mucosol
7,5 мг/мл 2 ml №5
Solution for infusions
Active ingredient
Ambroxol hydrochloride
Pharmacotherapeutic group

Agents affecting the respiratory system

More
7,5 мг/мл 2 ml №5 R05CB06
Suprostilin
 
Suprostilin
0,025 g № 10, № 20
Tablets
Active ingredient
Chloropyramine hydrochloride
Pharmacotherapeutic group

Agents affecting the respiratory system

More
0,025 g № 10, № 20 R06AC03
V.
3
Miscellaneous agents
V.

Miscellaneous agents

Name Dosage form ATC code
Calcium folinate
 
Calcium folinate
10 mg/ml 5 ml № 5
Solution for injections
Active ingredient
Folinic acid
Pharmacotherapeutic group

Miscellaneous agents

More
10 mg/ml 5 ml № 5 V03AF03
Water for injections
 
Water for injections
2 ml № 10
Solvent for parenteral administration
Active ingredient
Water for injections
Pharmacotherapeutic group

Miscellaneous agents

More
2 ml № 10 V07AB
Water for injections
 
Water for injections
5 ml № 10
Solvent for parenteral administration
Active ingredient
Water for injections
Pharmacotherapeutic group

Miscellaneous agents

More
5 ml № 10 V07AB
HP.
15
Healthcare Products
HP.
Healthcare Products
Name Dosage form ATC code
AllSept
 
AllSept
500 ml, 1000 ml, 5000 ml
Solution for external administration
Active ingredient
Isopropyl alcohol, benzalkonium chloride, purified water
Pharmacotherapeutic groupHealthcare Products
More
500 ml, 1000 ml, 5000 ml
AllSept 75
 
AllSept 75
50 ml
Solution for external administration
Active ingredient
Isopropyl alcohol, benzalkonium chloride, purified water
Pharmacotherapeutic groupHealthcare Products
More
50 ml
Bifolac
 
Bifolac
№ 5, № 10
Vaginal suppositories
Active ingredient
Lactic and bifidumbacteria
Pharmacotherapeutic groupHealthcare Products
More
№ 5, № 10 -
Fitoprost
 
Fitoprost
№ 5, № 10
Rectal suppositories
Active ingredient
Palmetto dry extract, pumpkin seed dry extract, nettle root dry extract
Pharmacotherapeutic groupHealthcare Products
More
№ 5, № 10 -
L-carnitine
 
L-carnitine
100 ml
Syrup
Active ingredient
L-carnitine
Pharmacotherapeutic groupHealthcare Products
More
100 ml -
Lactovag
 
Lactovag
№ 5, № 10
Vaginal suppositories
Active ingredient
Lactic bacteria
Pharmacotherapeutic groupHealthcare Products
More
№ 5, № 10 -
Lakarne
 
Lakarne
10 ml, 100 ml
Syrup
Active ingredient
L-carnitine
Pharmacotherapeutic groupHealthcare Products
More
10 ml, 100 ml -
Oblepiol
 
Oblepiol
1,4 g № 10
Suppositories
Active ingredient
Sea-buckthorn oil that contains total carotenoids in terms of betacarotene; and tea-seed oil
Pharmacotherapeutic groupHealthcare Products
More
1,4 g № 10
Saccharin-T
 
Saccharin-T
50 tablets, 0,1 g
Tablets
Active ingredient
Pharmacotherapeutic groupHealthcare Products
More
50 tablets, 0,1 g -
SanteFem
 
SanteFem
№ 10, № 14
Vaginal suppositories
Active ingredient
Boric acid, Vitamin E, Tea tree oil, Sodium hyaluronate
Pharmacotherapeutic groupHealthcare Products
More
№ 10, № 14 -
Tablets Pechaevskie
 
Tablets Pechaevskie
with raspberry taste
Tablets
Active ingredient
Pharmacotherapeutic groupHealthcare Products
More
with raspberry taste -
Tablets Pechaevskie
 
Tablets Pechaevskie
with mint taste
Tablets
Active ingredient
Pharmacotherapeutic groupHealthcare Products
More
with mint taste -
Tablets Pechaevskie
 
Tablets Pechaevskie
with forest berry taste
Tablets
Active ingredient
Pharmacotherapeutic groupHealthcare Products
More
with forest berry taste -
Tablets Pechaevskie
 
Tablets Pechaevskie
with tangerine taste
Tablets
Active ingredient
Pharmacotherapeutic groupHealthcare Products
More
with tangerine taste -
Tablets Pechaevskie
 
Tablets Pechaevskie
with no-sugar contains
Tablets
Active ingredient
Pharmacotherapeutic groupHealthcare Products
More
with no-sugar contains -
  • About company
    • Managing company “Lekhim”
    • Manufacturing site “Lekhim-Kharkiv”
    • Manufacturing site “Technolog”
    • Safety and pharmacovigilance (Technolog)
    • Safety and pharmacovigilance (Kharkiv)
    • News/Events
    • Partners
  • Products
    • Browse by group of action
    • Browse alphabetically
    • Browse by active ingredient
  • Export
    • Foreign economic activity
  • Contact information
Поиск по сайту
Designed in
© 2025. Лекхим.
  • Main
  • About company
    • About company
    • PJSC "Technolog"
    • PJSC “Lekhim-Kharkiv”
    • Lekhim-Obukhiv LLC
    • UAB «LEKHIM-VILNIUS»
    • FP «LEKHIM» LLC
    • Safety and pharmacovigilance (Technolog)
    • Safety and pharmacovigilance (Kharkiv)
    • Partners
  • Production
    • Medicinal products
    • Veterinary products
    • Natural drinking water Enjoy
    • Natural drinking water Cenoman
  • PHARMACIES
  • Export
  • News
  • Contacts
Поиск по сайту
Поиск по сайту